GORDON RINGOLD

Profile

First Name

: GORDON

Middle Name

:

Last Name

: RINGOLD

Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER, DIRECTOR
ALAVITA PHARMACEUTICALS INC
SAM COLELLA, RICHARD LERNER, ISAAC STEIN, ALEX ZAFFARONI
DIRECTOR
ALEXZA PHARMACEUTICALS INC.
HAL V BARRON, J KEVIN BUCHI, ANDREW L BUSSER, JAMES V CASSELLA, SAMUEL D COLELLA, SAMUEL D. COLELLA, ALAN D FRAZIER, EDWIN S KAMEMOTO, THOMAS B KING, ROBERT A LIPPE, ROBERT A. LIPPE, AUGUST J MORETTI, MARK K OKI, DEEPIKA R PAKIANATHAN, J LEIGHTON READ, MICHAEL J SIMMS, ISAAC STEIN, JOSEPH L TURNER, JOSEPH L. TURNER
DIRECTOR
3-V BIOSCIENCES, INC.
JOHN CURNUTTE, XUFANG DUAN, JASON FULLER, ROBERT GARLAND, ARI HELENIUS, REKHA HEMRAJANI, DENNIS HOM, GEORGE KEMBLE, RICK KLAUSNER, DAVID MOTT, MERDAD PARSEY, RICHARD RODGERS, BETH SEIDENBERG, JINZI JASON WU, JAMES YOUNG
DIRECTOR, PROMOTER
MAVERIX BIOMICS, INC.
PATRICIA PAK LEE CHAN, TODD MICHAEL JOHNSON LOWE, DAVID MANDELKERN, PAUL PICKERING
EXECUTIVE OFFICER, DIRECTOR
PROTEIN METRICS INC.
CHRISTOPHER BECKER, MARSHALL BERN, ANDREW YANG
DIRECTOR
ARDELYX, INC.
ROBERT BAZEMORE, WILLIAM BERTRAND, JR., JEREMY CALDWELL, DOMINIQUE CHARMOT, DAVID COLLIER, JEAN FRECHET, ELIZABETH GRAMMER, JEFF JACOBS, ANNALISA JENKINS, MARK KAUFMANN, PAUL KORNER, DAVID MOTT, MICHAEL RAAB, RICHARD RODGERS, DAVID ROSENBAUM, PETER SCHULTZ, PETER G. SCHULTZ
DIRECTOR
SAGIMET BIOSCIENCES INC.
JOHN CURNUTTE, XUFANG DUAN, JASON FULLER, ROBERT GARLAND, ARI HELENIUS, REKHA HEMRAJANI, DENNIS HOM, GEORGE KEMBLE, RICK KLAUSNER, DAVID MOTT, MERDAD PARSEY, RICHARD RODGERS, BETH SEIDENBERG, JINZI JASON WU, JAMES YOUNG
DIRECTOR
APEXIGEN, INC.
HERB CROSS, WILLIAM DUKE, JR., JAKOB DUPONT, FRANK HSU, MEENU KARSON, FRANCIS SARENA, SCOTT SMITH, SAMUEL WERTHEIMER, AMY WONG, XIAODONG YANG, DAN ZABROWSKI
EXECUTIVE OFFICER, DIRECTOR
MAXYMUNE THERAPEUTICS, INC.
TATJANA NARANDA, NEIL SOLOMONS
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-06-03
D/A
Link
BIOTECHNOLOGY 
 
NO REVENUES 
 
2025-02-11 
2025-02-28
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
 
2025-02-11 
2023-02-14
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2023-01-30 
2021-01-05
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-12-21 
2019-02-25
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-02-12 
2016-08-01
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2016-07-18 
2016-07-05
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2016-06-17 
2016-02-24
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2016-02-23 
2015-09-28
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2015-09-28 
2015-06-22
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2015-06-05 
2015-03-17
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-10-22 
2014-10-28
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2014-10-27 
2014-03-28
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2014-03-18 
2014-02-19
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2014-02-10 
2014-01-03
D
Link
OTHER TECHNOLOGY 
 
$1 - $1,000,000 
Equity 
2013-12-18 
2013-06-27
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-06-14 
2012-12-20
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-11-29 
2012-03-16
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2012-03-15 
2011-12-12
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-11-29 
2010-05-12
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2010-05-04 
2009-10-06
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2009-10-05 
2009-09-22
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-09-10 
2009-08-27
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2009-08-26 
2009-07-22
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-07-07